Medtronic Enters Into $268M Settlement to End Lawsuit Related to its Defibrillation Leads

Minneapolis-based Medtronic has agreed to pay $268 million to the government to end a three-year legal battle surrounding one of its products, according to a company news release.

The case against Medtronic alleges the company manufactured defective defibrillation leads that led to the deaths of at least 13 people who received the implants. Following this incident, Medtronic recalled the product. Under the terms of the agreement, Medtronic will pay $268 million and all multi-district litigations and state court proceedings related to this case will be terminated. The plaintiff's pending appeals will also be dismissed, according to the news release.

As part of the settlement, Medtronic is not admitting any liability.

Read the news release about Medtronic's settlement.

Read other coverage about settlements:

- St. Louis-Area Internist, Employer to Pay $1.6M to Settle Medicare Fraud Case

- Medical Device Maker, Government Reach Tentative $10M Settlement for Alleged Kickback Scheme

- CHRISTUS Health in Houston to Pay $1M Settlement in Medicare Fraud Lawsuit

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers